Latest news
TG Therapeutics (TGTX) Is Down 7.4% After Q2 Profit Drop Despite Higher 2026 Revenue Guidance – Has The Bull Case Changed? - SahmSahm · Sat, 08 Aug 2026 18:38:48 GMTTG Therapeutics (TGTX) Stock Looks Reasonable On Earnings Yet Stretched After 386% Run - SahmSahm · Sat, 01 Aug 2026 07:00:00 GMTDid Briumvi’s Strong Trial Data and New Schizophrenia Study Just Shift TG Therapeutics’ (TGTX) Investment Narrative? - SahmSahm · Wed, 29 Jul 2026 07:00:00 GMT